| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10818135 | Clinical Biochemistry | 2005 | 6 Pages |
Abstract
The method described here will enable large-scale clinical pharmacokinetic studies on Photofrin II; investigations can now address possible correlations between individual concentrations of drug-derived plasma porphyrins and systemic photosensitivity-representing the main side effect of Photofrin II-with the perspective of individualized light protection regimens after Photofrin II administration.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Michael Vogeser, Moshe Schaffer, Emil Egeler, Ute Spöhrer,